Soliris and Hyperbilirubinaemia aggravated - a phase IV clinical study of FDA data

Summary:

Hyperbilirubinaemia aggravated is reported as a side effect among people who take Soliris (eculizumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Arixtra, and have Paroxysmal nocturnal haemoglobinuria.

The phase IV clinical study analyzes which people have Hyperbilirubinaemia aggravated when taking Soliris. It is created by eHealthMe based on reports of 58,774 people who have side effects when taking Soliris from the FDA, and is updated regularly.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.

What is Hyperbilirubinaemia aggravated?

Hyperbilirubinaemia aggravated (excess of bilirubin in the blood) is found to be associated with 811 drugs and 378 conditions by eHealthMe. Check the latest studies of Hyperbilirubinaemia aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

58,774 people reported to have side effects when taking Soliris.
Among them, 38 people (0.06%) have Hyperbilirubinaemia aggravated.

Could Soliris cause Hyperbilirubinaemia aggravated?

Among these 38 people:

How long have people been on Soliris when they have Hyperbilirubinaemia aggravated? *

What is the gender of people who have Hyperbilirubinaemia aggravated when taking Soliris? *

female: 39.29 %
male: 60.71 %

What is the age of people who have Hyperbilirubinaemia aggravated when taking Soliris? *

What are other drugs people take besides Soliris? *

What are other side effects people have besides Hyperbilirubinaemia aggravated? *

Extravascular Haemolysis: 9 people, 23.68%
Blood Lactate Dehydrogenase Increased: 9 people, 23.68%
Anaemia (lack of blood): 6 people, 15.79%
Reticulocytosis (a condition where there is an increase in reticulocytes): 6 people, 15.79%
Haemoglobin Decreased: 5 people, 13.16%
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid): 4 people, 10.53%
Fatigue (feeling of tiredness): 4 people, 10.53%
Gallstones (stone formation by bile component): 4 people, 10.53%
Diarrhea: 4 people, 10.53%
Liver Disorder (liver diseases): 4 people, 10.53%

What are the existing conditions these people have? *

Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 26 people, 68.42%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 5 people, 13.16%
Pain: 3 people, 7.89%
High Blood Pressure: 2 people, 5.26%
Aplastic Anemia: 2 people, 5.26%
Insomnia (sleeplessness): 2 people, 5.26%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 5.26%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 2.63%
Agitation (state of anxiety or nervous excitement): 1 person, 2.63%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Soliris and have Hyperbilirubinaemia aggravated?

- Check whether Hyperbilirubinaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Soliris:

Soliris (58,821 reports)

Browse all side effects of Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperbilirubinaemia aggravated:

Hyperbilirubinaemia aggravated (811 drugs)

Browse all the conditions that are associated with Hyperbilirubinaemia aggravated:

Hyperbilirubinaemia aggravated (378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eculizumab (the active ingredients of Soliris) and Soliris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.